These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16254730)

  • 21. Child and parent perceptions of stimulant medication treatment in attention deficit hyperactivity disorder.
    Efron D; Jarman FC; Barker MJ
    J Paediatr Child Health; 1998 Jun; 34(3):288-92. PubMed ID: 9633980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardiovascular risks and management during Attention Deficit Hyperactivity Disorder treatment with methylphenidate].
    Bange F; Le Heuzey MF; Acquaviva E; Delorme R; Mouren MC
    Arch Pediatr; 2014 Jan; 21(1):108-12. PubMed ID: 24309201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
    Aman MG; Binder C; Turgay A
    J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options.
    Hodgkins P; Shaw M; Coghill D; Hechtman L
    Eur Child Adolesc Psychiatry; 2012 Sep; 21(9):477-92. PubMed ID: 22763750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study.
    Biederman J; Boellner SW; Childress A; Lopez FA; Krishnan S; Zhang Y
    Biol Psychiatry; 2007 Nov; 62(9):970-6. PubMed ID: 17631866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study.
    Firestone P; Musten LM; Pisterman S; Mercer J; Bennett S
    J Child Adolesc Psychopharmacol; 1998; 8(1):13-25. PubMed ID: 9639076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
    Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
    Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autonomic correlates at rest and during evoked attention in children with attention-deficit/hyperactivity disorder and effects of methylphenidate.
    Negrao BL; Bipath P; van der Westhuizen D; Viljoen M
    Neuropsychobiology; 2011; 63(2):82-91. PubMed ID: 21178382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial.
    Gillberg C; Melander H; von Knorring AL; Janols LO; Thernlund G; Hägglöf B; Eidevall-Wallin L; Gustafsson P; Kopp S
    Arch Gen Psychiatry; 1997 Sep; 54(9):857-64. PubMed ID: 9294377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose.
    Castellanos FX; Giedd JN; Elia J; Marsh WL; Ritchie GF; Hamburger SD; Rapoport JL
    J Am Acad Child Adolesc Psychiatry; 1997 May; 36(5):589-96. PubMed ID: 9136492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing the ability of children with attention deficit hyperactivity disorder to accurately report the effects of medication on their behavior.
    Ardoin SP; Martens BK
    J Appl Behav Anal; 2000; 33(4):593-610. PubMed ID: 11214033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: a preliminary double-blind placebo controlled trial.
    Cox DJ; Merkel RL; Kovatchev B; Seward R
    J Nerv Ment Dis; 2000 Apr; 188(4):230-4. PubMed ID: 10790000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD.
    Winterstein AG; Gerhard T; Shuster J; Saidi A
    Pediatrics; 2009 Jul; 124(1):e75-80. PubMed ID: 19564272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-hyperactivity medication: methylphenidate and amphetamine.
    Seeman P; Madras BK
    Mol Psychiatry; 1998 Sep; 3(5):386-96. PubMed ID: 9774771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.
    Varley CK; Vincent J; Varley P; Calderon R
    Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A long-term open-label safety and effectiveness trial of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder.
    Findling RL; Cutler AJ; Saylor K; Gasior M; Hamdani M; Ferreira-Cornwell MC; Childress AC
    J Child Adolesc Psychopharmacol; 2013 Feb; 23(1):11-21. PubMed ID: 23410138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity.
    Fredriksen M; Dahl AA; Martinsen EW; Klungsøyr O; Haavik J; Peleikis DE
    Eur Neuropsychopharmacol; 2014 Dec; 24(12):1873-84. PubMed ID: 25453480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide association study of blood pressure response to methylphenidate treatment of attention-deficit/hyperactivity disorder.
    Mick E; McGough JJ; Middleton FA; Neale B; Faraone SV
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):466-72. PubMed ID: 21130132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress.
    Swanson J; Baler RD; Volkow ND
    Neuropsychopharmacology; 2011 Jan; 36(1):207-26. PubMed ID: 20881946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attention deficit hyperactivity disorder in children.
    Ramchandani P; Joughin C; Zwi M
    Clin Evid; 2002 Jun; (7):262-71. PubMed ID: 12230649
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.